- Nachrichtendetail
-
21.05.2024 13:19:02 - dpa-AFX: *HALOZYME: BRISTOL MYERS SQUIBB GETS UPDATED ACTION DATE OF DEC. 29 FOR SUBCUTANEOUS NIVOLUMAB CO-FORMULATED WITH ENHANZE
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Bristol-Myers Squibb Co | 850501 | NYSE | 40,905 | 11.07.24 20:43:44 | -0,215 | -0,52% | 40,900 | 40,910 | 40,870 | 41,120 |
